Adaptimmune Therapeutics PLC (NAS:ADAP)
$ 0.29 +0.017 (+6.19%) Market Cap: 76.86 Mil Enterprise Value: 61.53 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 60/100

Adaptimmune Therapeutics PLC (ADAP) Transcripts

  • 1